Bimekizumab-induced eczematous eruption treated successfully with sequential upadacitinib and dupilumab therapy. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 9, n. 3, p. 2330–2333, 2025. DOI: 10.25251/skin.9.3.8. Disponível em: https://skin.dermsquared.com/skin/article/view/3196. Acesso em: 18 apr. 2026.